MedPath

Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.

Not Applicable
Completed
Conditions
Women's Health
Interventions
Dietary Supplement: Perelel Health Hormonal Balance Support
Registration Number
NCT06535698
Lead Sponsor
Perelel Inc.
Brief Summary

This is a virtual single-group trial lasting 12 weeks to evaluate the effects of Perelel Health's hormonal balance support on symptoms of hormonal imbalance and overall menstrual health.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
35
Inclusion Criteria
  • Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles)
  • Generally healthy without uncontrolled chronic diseases
  • Willing to avoid new hormonal balance treatments during the study
  • Consistent use of current hormonal balance treatments for at least 3 months prior to the study
Exclusion Criteria
  • Chronic conditions preventing adherence to the protocol Diabetes
  • Planned hormonal balance-related procedures during the study
  • Started any new medications or supplements that target hormonal balance in the past 3 months
  • Anyone with diabetes
  • Severe allergies requiring EpiPen
  • Pregnant, breastfeeding, or trying to conceive
  • Recent surgeries or planned surgeries during the study
  • Unwilling to follow the study protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hormonal Balance Support SupplementPerelel Health Hormonal Balance SupportParticipants in this arm will receive Perelel Health hormonal balance support capsules. The dosage regimen is as follows: Week 1: 1 capsule daily in the evening Week 2: 2 capsules daily in the evening Weeks 3-12: 4 capsules daily (2 in the morning and 2 in the evening) The supplement contains Myo-inositol (1000 mcg), Metabolic balance blend (200 mcg) including Berberine HCl, Alpha lipoic acid, DIM (33'-Diindolylmethane), and D-chiro-inositol (25 mg). Other ingredients include Vegetable cellulose (capsule), plant cellulose, and L-leucine.
Primary Outcome Measures
NameTimeMethod
Changes in Symptoms of Hormonal ImbalanceBaseline, Week 4, Week 8, Week 12

Evaluation of the effect of Perelel Health hormonal balance support on symptoms of hormonal imbalance using a self-reported questionnaire.

Secondary Outcome Measures
NameTimeMethod
Changes in Overall Menstrual HealthBaseline, Week 4, Week 8, Week 12

Assessment of the impact of Perelel Health hormonal balance support on menstrual health using a self-reported questionnaire.

Trial Locations

Locations (1)

Citruslabs

🇺🇸

Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath